Related Experiment Videos
N-formyl-methionyl-leucyl-phenylalanine induces and modulates IL-1 and IL-6 in human PBMC
1Centre de recherches en immunologie, Institut Armand-Frappier, CP 100, Laval-des-Rapides, Québec, Canada.
Abstract:
N-formyl-methionyl-leucyl-phenylalanine (fMLP), a bacterial derivative, induces and modulates various cellular responses linked to inflammation. In this work we evaluated the impact of fMLP stimulation on three pro-inflammatory cytokines: IL-1 alpha, IL-1 beta and IL-6. We found that fMLP induces the secretion of IL-1 alpha, IL-1 beta and IL-6 in human peripheral blood mononuclear cells (PBMC). It also increased LPS-induced secretion of these three cytokines. Northern blot analysis demonstrated that fMLP induced IL-1 alpha, IL-1 beta and IL-6 gene expression by human PBMC. The fMLP-induced IL-1 alpha and IL-1 beta gene expression and IL-6 secretion were abolished by pertussis toxin pretreatment, which suggests that the fMLP induction of cytokine was also mediated via a Gi protein. The concentration range of fMLP used to obtain these effects, in a dose dependent fashion, was 20 microM to 1100 microM. The mechanism by which fMLP modulates cytokine secretion is still not characterized. fMLP seems to share similar biological activities with other chemotactic factors (C5a, MCP-1, PAF, IL-8) that are able to modulate cytokines, and whose receptors belong to the same superfamily as the fMLP receptor(s).
Insights
N-formyl-methionyl-leucyl-phenylalanine (fMLP) stimulates the release and gene expression of pro-inflammatory cytokines IL-1 alpha, IL-1 beta, and IL-6 in human immune cells. This response is partly mediated by Gi proteins, suggesting a role in inflammatory signaling pathways.
Area of Science:
- Immunology
- Molecular Biology
- Cellular Biology
Background:
- N-formyl-methionyl-leucyl-phenylalanine (fMLP) is a bacterial-derived molecule known to influence cellular functions.
- Inflammation involves complex cellular responses, including the modulation of pro-inflammatory cytokines.
- Human peripheral blood mononuclear cells (PBMC) are key players in immune responses.
Purpose of the Study:
- To investigate the effect of fMLP on the secretion and gene expression of IL-1 alpha, IL-1 beta, and IL-6.
- To explore the signaling pathways involved in fMLP-induced cytokine modulation.
- To compare fMLP's effects with other known chemotactic factors.
Main Methods:
- Stimulation of human PBMC with varying concentrations of fMLP.
- Measurement of cytokine secretion using appropriate assays.
- Analysis of cytokine gene expression via Northern blot.
- Pretreatment with pertussis toxin to investigate signaling pathways.
Main Results:
- fMLP significantly induced the secretion of IL-1 alpha, IL-1 beta, and IL-6 in human PBMC.
- fMLP also enhanced lipopolysaccharide (LPS)-induced secretion of these cytokines.
- Northern blot confirmed that fMLP upregulated the gene expression of IL-1 alpha, IL-1 beta, and IL-6.
- Pertussis toxin pretreatment blocked fMLP-induced IL-1 alpha and IL-1 beta gene expression and IL-6 secretion, indicating Gi protein involvement.
- The observed effects were dose-dependent, occurring within a concentration range of 20 to 1100 microM fMLP.
Conclusions:
- fMLP is a potent inducer of pro-inflammatory cytokines IL-1 alpha, IL-1 beta, and IL-6 in human PBMC.
- The induction of these cytokines by fMLP is, in part, mediated through Gi protein-coupled receptors.
- fMLP shares functional similarities with other chemotactic factors in modulating cytokine responses, suggesting a conserved signaling mechanism within this receptor superfamily.